Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation and Previous Major Gastrointestinal Bleeding (from the Amplatzer Cardiac Plug Multicenter Registry).
[en] History of major gastrointestinal (GI) bleeding may represent a frequent clinical indication for left atrial appendage occlusion (LAAO) in patients with non-valvular atrial fibrillation (AF). This study aims to investigate the procedural safety and long-term outcome of patients with previous major GI bleeding (MGIB) who underwent LAAO. Data from the Amplatzer Cardiac Plug multicenter registry on 1,047 patients were analyzed. Patients with previous MGIB as indication for LAAO were compared with patients without previous MGIB. A total of 151 patients (14.4%) with previous MGIB were identified. Periprocedural major bleeding events were more frequent in patients with previous MGIB (4.0% vs 0.8%, p = 0.001). With an average follow-up of 1.3 years, the observed annual rate of stroke/transient ischemic attack and major bleeding for patients with previous MGIB were 2.1% (61.4% relative reduction according to the Congestive Heart failure, Hypertension, Age >/=75 (doubled), Diabetes, Stroke (doubled), Vascular disease, Age 65-74, and Sex (female) [CHA2DS2-VASc] score) and 4.6% (20.1% relative reduction according to the expected rate based on the Hypertension, Abnormal renal/liver function (1 point each), Stroke, Bleeding history or predisposition, Labile INR, Elderly (>65 years), Drugs/alcohol concomitantly (1 point each) [HAS-BLED] score), respectively. In conclusion, in patients with non-valvular atrial fibrillation and previous MGIB, LAAO was associated with a low annual rate of stroke/transient ischemic attack. Periprocedural major bleeding events were more frequent in this specific population although the annual major bleeding rate showed a 20.1% relative risk reduction according to the HAS-BLED score.
Disciplines :
Cardiovascular & respiratory systems
Author, co-author :
LEMPEREUR, Mathieu ; Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Cardiologie interventionnelle
Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation and Previous Major Gastrointestinal Bleeding (from the Amplatzer Cardiac Plug Multicenter Registry).
Publication date :
2017
Journal title :
American Journal of Cardiology
ISSN :
0002-9149
eISSN :
1879-1913
Publisher :
Elsevier, New York, United States - New York
Volume :
120
Issue :
3
Pages :
414-420
Peer reviewed :
Peer Reviewed verified by ORBi
Commentary :
Copyright (c) 2017 Elsevier Inc. All rights reserved.
Hallas, J., Dall, M., Andries, A., Andersen, B.S., Aalykke, C., Hansen, J.M., Andersen, M., Lassen, A.T., Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study. BMJ, 333, 2006, 726.
Saperas, E., Videla, S., Dot, J., Bayarri, C., Lobo, B., Abu-Suboh, M., Armengol, J.R., Malagelada, J.R., Risk factors for recurrence of acute gastrointestinal bleeding from angiodysplasia. Eur J Gastroenterol Hepatol 21 (2009), 1333–1339.
Niikura, R., Nagata, N., Yamada, A., Akiyama, J., Shimbo, T., Uemura, N., Recurrence of colonic diverticular bleeding and associated risk factors. Colorectal Dis 14 (2012), 302–305.
Fang, M.C., Go, A.S., Chang, Y., Hylek, E.M., Henault, L.E., Jensvold, N.G., Singer, D.E., Death and disability from warfarin-associated intracranial and extracranial hemorrhages. Am J Med 120 (2007), 700–705.
O'Brien, E.C., Simon, D.N., Allen, L.A., Singer, D.E., Fonarow, G.C., Kowey, P.R., Thomas, L.E., Ezekowitz, M.D., Mahaffey, K.W., Chang, P., Piccini, J.P., Peterson, E.D., Reasons for warfarin discontinuation in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). Am Heart J 168 (2014), 487–494.
Fang, M.C., Go, A.S., Chang, Y., Borowsky, L.H., Pomernacki, N.K., Udaltsova, N., Singer, D.E., Warfarin discontinuation after starting warfarin for atrial fibrillation. Circ Cardiovasc Qual Outcomes 3 (2010), 624–631.
Witt, D.M., Delate, T., Garcia, D.A., Clark, N.P., Hylek, E.M., Ageno, W., Dentali, F., Crowther, M.A., Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for gastrointestinal tract bleeding. Arch Intern Med 172 (2012), 1484–1491.
Lee, S.J., Shin, D.H., Hwang, H.J., Kim, J.Y., Pak, H.N., Lee, M.H., Joung, B., Bleeding risk and major adverse events in patients with previous ulcer on oral anticoagulation therapy. Am J Cardiol 110 (2012), 373–377.
Qureshi, W., Mittal, C., Patsias, I., Garikapati, K., Kuchipudi, A., Cheema, G., Elbatta, M., Alirhayim, Z., Khalid, F., Restarting anticoagulation and outcomes after major gastrointestinal bleeding in atrial fibrillation. Am J Cardiol 113 (2014), 662–668.
Lewalter, T., Kanagaratnam, P., Schmidt, B., Rosenqvist, M., Nielsen-Kudsk, J.E., Ibrahim, R., Albers, B.A., Camm, A.J., Ischaemic stroke prevention in patients with atrial fibrillation and high bleeding risk: opportunities and challenges for percutaneous left atrial appendage occlusion. Europace 16 (2014), 626–630.
Sengupta, N., Feuerstein, J.D., Patwardhan, V.R., Tapper, E.B., Ketwaroo, G.A., Thaker, A.M., Leffler, D.A., The risks of thromboembolism vs. recurrent gastrointestinal bleeding after interruption of systemic anticoagulation in hospitalized inpatients with gastrointestinal bleeding: a prospective study. Am J Gastroenterol 110 (2015), 328–335.
Tzikas, A., Shakir, S., Gafoor, S., Omran, H., Berti, S., Santoro, G., Kefer, J., Landmesser, U., Nielsen-Kudsk, J.E., Cruz-Gonzalez, I., Sievert, H., Tichelbacker, T., Kanagaratnam, P., Nietlispach, F., Aminian, A., Kasch, F., Freixa, X., Danna, P., Rezzaghi, M., Vermeersch, P., Stock, F., Stolcova, M., Costa, M., Ibrahim, R., Schillinger, W., Meier, B., Park, J.W., Left atrial appendage occlusion for stroke prevention in atrial fibrillation: multicentre experience with the AMPLATZER Cardiac Plug. EuroIntervention 11 (2016), 1170–1179.
Kappetein, A.P., Head, S.J., Genereux, P., Piazza, N., van Mieghem, N.M., Blackstone, E.H., Brott, T.G., Cohen, D.J., Cutlip, D.E., van Es, G.A., Hahn, R.T., Kirtane, A.J., Krucoff, M.W., Kodali, S., Mack, M.J., Mehran, R., Rodes-Cabau, J., Vranckx, P., Webb, J.G., Windecker, S., Serruys, P.W., Leon, M.B., Valve Academic Research Consortium (VARC)-2. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2). Eur J Cardiothorac Surg 42 (2012), S45–S60.
Mehran, R., Rao, S.V., Bhatt, D.L., Gibson, C.M., Caixeta, A., Eikelboom, J., Kaul, S., Wiviott, S.D., Menon, V., Nikolsky, E., Serebruany, V., Valgimigli, M., Vranckx, P., Taggart, D., Sabik, J.F., Cutlip, D.E., Krucoff, M.W., Ohman, E.M., Steg, P.G., White, H., Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation 123 (2011), 2736–2747.
Price, M.J., Reddy, V.Y., Valderrabano, M., Halperin, J.L., Gibson, D.N., Gordon, N., Huber, K.C., Holmes, D.R. Jr., Bleeding outcomes after left atrial appendage closure compared with long-term warfarin: a pooled, patient-level analysis of the WATCHMAN randomized trial experience. JACC Cardiovasc Interv 8 (2015), 1925–1932.
Boersma, L.V., Schmidt, B., Betts, T.R., Sievert, H., Tamburino, C., Teiger, E., Pokushalov, E., Kische, S., Schmitz, T., Stein, K.M., Bergmann, M.W., EWOLUTION investigators. Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry. Eur Heart J 37 (2016), 2465–2474.
Meerkin, D., Butnaru, A., Dratva, D., Bertrand, O.F., Tzivoni, D., Early safety of the Amplatzer Cardiac Plug for left atrial appendage occlusion. Int J Cardiol 168 (2013), 3920–3925.
Lopez Minguez, J.R., Asensio, J.M., Gragera, J.E., Costa, M., Gonzalez, I.C., de Carlos, F.G., Diaz, J.A., Martin Yuste, V., Gonzalez, R.M., Dominguez-Franco, A., Buendia, A.B., Garibi, J.H., Hernandez, F.H., Ribeiro, V.G., Two-year clinical outcome from the Iberian registry patients after left atrial appendage closure. Heart 101 (2015), 877–883.
Vorselaars, V.M., Velthuis, S., Swaans, M.J., Mager, J.J., Snijder, R.J., Rensing, B.J., Boersma, L.V., Post, M.C., Percutaneous left atrial appendage closure—an alternative strategy for anticoagulation in atrial fibrillation and hereditary hemorrhagic telangiectasia?. Cardiovasc Diagn Ther 5 (2015), 49–53.
Korsholm, K., Nielsen, K.M., Jensen, J.M., Jensen, H.K., Andersen, G., Nielsen-Kudsk, J.E., Transcatheter left atrial appendage occlusion in patients with atrial fibrillation and a high bleeding risk using aspirin alone for post-implant antithrombotic therapy. EuroIntervention 12 (2016), 2075–2082.
Tzikas, A., Holmes, D.R. Jr., Gafoor, S., Ruiz, C.E., Blomstrom-Lundqvist, C., Diener, H.C., Cappato, R., Kar, S., Lee, R.J., Byrne, R.A., Ibrahim, R., Lakkireddy, D., Soliman, O.I., Nabauer, M., Schneider, S., Brachman, J., Saver, J.L., Tiemann, K., Sievert, H., Camm, A.J., Lewalter, T., Percutaneous left atrial appendage occlusion: the Munich consensus document on definitions, endpoints and data collection requirements for clinical studies. EuroIntervention 12 (2016), 103–111.
